# FDA Inspection 1005001 - Sharon B. Wigal, Ph. D. - March 06, 2017

Source: https://www.keypedia.com/records/fda_inspections/sharon-b-wigal-ph-d/d8942288-5e8f-4a03-b7c0-4fd4047bd649
Source feed: FDA_Inspections

> FDA Inspection 1005001 for Sharon B. Wigal, Ph. D. on March 06, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005001
- Company Name: Sharon B. Wigal, Ph. D.
- Inspection Date: 2017-03-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 909257 - 2014-12-18](https://www.keypedia.com/records/fda_inspections/sharon-b-wigal-ph-d/5fc833f0-75e3-4228-84f3-1bfddf6d6d67)
- [FDA Inspection 699416 - 2010-11-18](https://www.keypedia.com/records/fda_inspections/sharon-b-wigal-ph-d/cf3c4846-e996-42c0-938a-c649f9343476)

Company: https://www.keypedia.com/companies/sharon-b-wigal-ph-d/9bd4550f-a6c4-4ac0-9d6f-6aa8dc14cef0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c